Inclusion criteria | Exclusion criteria |
---|---|
(1) Ginsenoside were administered. | (1) Ginsenoside were not administered. |
(2) Experimental AD was induced in rodents (i.e., rats or mice). | (2) Other types of animals (e.g., sheep, cats, and dogs) were used. |
(3) AD treatment group was treated with a pharmacological agent, and a control group was administered a placebo after injury. | (3) Treatment group was administered another neuroprotective agent in addition to ginsenoside. |
(4) Cognitive function was measured by the MWM. | (4) Treatment group was administered another Chinese Traditional medicine in addition to ginsenoside. |
(5) Article was published in English or Chinese language. | (5) Only biochemical or physiological outcomes of treatment efficacy were assessed. |
(6) No control group was used. (8) Duplicate publications. |